[PDF][PDF] Arterial revascularization versus metal stents for multivessel diseases: a shifting frontier
R Beyar, L Gruberg - IMAJ-RAMAT GAN-, 2002 - ima.org.il
… a pattern that is similar to the ARTS trial, with similar rates of … In the current study, the
revascularization was complete in … incomplete revascularization had a lower event-free survival (…
revascularization was complete in … incomplete revascularization had a lower event-free survival (…
Association between completeness of percutaneous coronary revascularization and postprocedure outcomes
… , but little is known about its impact on PCI outcomes. This study … the Arterial Revascularization
Therapies Study (ARTS) group … PCI trial of complete versus incomplete revascularization. …
Therapies Study (ARTS) group … PCI trial of complete versus incomplete revascularization. …
Five-year follow-up of the medicine, angioplasty, or surgery study (MASS II) a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary …
… in the Arterial Revascularization Therapies Study (ARTS), which … higher complete anatomic
revascularization compared with … independent predictor of lower rates of event-free survival. …
revascularization compared with … independent predictor of lower rates of event-free survival. …
Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute …
… has frequently been observed in patients undergoing complete surgical revascularization, 1…
effect of completeness of revascularization on event-free survival at one year in the ARTS trial…
effect of completeness of revascularization on event-free survival at one year in the ARTS trial…
Drug‐Eluting Stents for Interventional Revascularization of Coronary Multivessel Disease
ATL Ong, WJ van der Giessen - Journal of Interventional …, 2005 - Wiley Online Library
… Complete Revascularization The subanalysis from the ARTS trial demonstrated that at 1 year
… group, patients experienced a similar event-free survival irrespective of whether they were …
… group, patients experienced a similar event-free survival irrespective of whether they were …
[HTML][HTML] Coronary revascularization in diabetic patients: current state of evidence
M Singh, R Arora, V Kodumuri, S Khosla… - Experimental & Clinical …, 2011 - ncbi.nlm.nih.gov
… The event-free survival rate at one year was reduced in … compared with the CABG arm in
the ARTS trial (65). To make the … in providing complete revascularization is exemplified in the …
the ARTS trial (65). To make the … in providing complete revascularization is exemplified in the …
The prognostic value of residual coronary stenoses after functionally complete revascularization
Y Kobayashi, CW Nam, PAL Tonino, T Kimura… - Journal of the American …, 2016 - jacc.org
… Therefore, we hypothesized that after “functionally” complete revascularization with FFR …
effect of completeness of revascularization on event-free survival at one year in the ARTS trial…
effect of completeness of revascularization on event-free survival at one year in the ARTS trial…
Impact of chronic kidney disease on long-term outcomes in type 2 diabetic patients with coronary artery disease on surgical, angioplasty, or medical treatment
… an attempt to accomplish complete revascularization. Use of … We saw no difference among
event-free survival of different … assigned from the MASS II trial observed that, in patients with …
event-free survival of different … assigned from the MASS II trial observed that, in patients with …
[PDF][PDF] … effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial
W Lindeboom, F Unger, PW Serruys - 2005 - Citeseer
… revascularization procedure when compared with 8.2% in the surgery group (P ¼ 0.08). The
event-free survival at … taken place since the completion of recruitment in the ARTS trial. Drug-…
event-free survival at … taken place since the completion of recruitment in the ARTS trial. Drug-…